cilnidipine

0 marketed 1 in Phase 3

This page covers all cilnidipine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Voltage-dependent N-type calcium channel subunit alpha-1B, Voltage-dependent T-type calcium channel subunit alpha-1H, Voltage-gated L-type calcium channel.

Targets

Voltage-dependent N-type calcium channel subunit alpha-1B, Voltage-dependent T-type calcium channel subunit alpha-1H, Voltage-gated L-type calcium channel

Phase 3 pipeline (1)

Patent intelligence